MiMedx Group (NASDAQ:MDXG) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reissued their buy rating on shares of MiMedx Group (NASDAQ:MDXG – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $11.00 price objective on the stock. HC Wainwright also issued estimates for MiMedx Group’s Q2 2024 earnings at $0.10 EPS, Q3 2024 earnings at $0.10 EPS, […]

Related Keywords

Dekabank Deutsche Girozentrale ,Riccis Whitlow ,Mt Bank Corp ,E Fund Management Co ,News Ratings For Mimedx Group Daily ,Securities Exchange Commission ,Mimedx Group Inc ,Mimedx Group Stock Performance ,Institutional Trading Of Mimedx Group ,Mimedx Group ,Free Report ,Street Capital ,Medx Group ,Get Free Report ,Frank Iv Hulse ,Exchange Commission ,Bank Deutsche Girozentrale ,Mimedx Group Daily ,Nasdaq Mdxg ,Mdxg ,Medical ,Reiterated Rating ,Hc Wainwright ,